Posts Tagged: Mayo v. Prometheus


Part 2: A Conversation with Chisum and Mueller

MUELLER: "I think a lot is going to ride on what we see going forward from the PTAB, for example decisions in post grant review. Will those …
By Gene Quinn
5 years ago 2

Patent Eligibility in Unsettled Times

Today, after several years of substantial turmoil, patent eligibility in a variety of economically significant technologies is extremely uncertain, including software, natural products, medical diagnostics and personalized …
By Gene Quinn
6 years ago 17

Industry Insiders Reflect on Biggest Moments in IP for 2012

For this inaugural edition of ?Biggest Moments in IP? we have a variety of reflections on a wide array of IP issues. Former Commissioner for Patents Bob …
By Gene Quinn
6 years ago 2

Business Methods (and Software) are Still Patentable!

For at least the past 15 years, the legal, technical and academic communities have been debating the patentability of business methods and software. Despite much negative press ink, …
By Raymond Millien
7 years ago 4

Bob Stoll Part 2 – Innovation, Economy, Patent Examination

In part 1 of my interview with Stoll we discussed his adjusting to life in the private sector, the fact that he doesn't enjoy the billable hour part …
By Gene Quinn
7 years ago 2

The U.S. Government’s Position in ACLU v. Myriad Genetics: Observations on a ‘Waste of Time and Space’

So maybe the Federal Circuit won’t find “preemption” to be useful in deciding this appeal; we’ll know soon enough. I, for one, can’t make …
By Hans Sauer
7 years ago 6

Federal Circuit Panel Rehears ACLU, Myriad Gene Patent Case

Although predictions on the outcome of an unusual case such as this are probably worthless, I think that it is most likely that this panel will rule …
By Ryan Chirnomas
7 years ago 8

CLS Bank v. Alice Corporation Reveals “A House Divided”

The decision of the Supreme Court in Prometheus has been predicted to have implications for business method patentability, but the decision in what will surely become known …
By Paul Cole
7 years ago 30

A Guide to Limiting the Damage Done by the Supremes in Mayo

Now the Patent Office and the courts have the unenviable task of trying to figure out what the Supreme Court really meant in Mayo v. Prometheus. If …
By Gene Quinn
7 years ago 37

Prometheus v. Mayo – The Wrong Rat?

A decision with the right outcome but for the wrong reasons can confound jurisprudence nearly as much as a decision that is entirely wrong. It is difficult …
By Paul Cole
7 years ago 17

Divining What Mayo Means: Exploring the SmartGene Case*

Trying to divine what Mayo Collaborative Services v. Prometheus Laboratories, Inc. means for the future in judging the patent-eligibility of claimed methods and processes under 35 U.S.…
By Eric Guttag
7 years ago 21

Insiders React to Supreme Court Prometheus Decision

Just over three weeks ago the United States Supreme Court issued a decision in Mayo Collaborative Services v. Prometheus Laboratories, which sent much of the patent world …
By Gene Quinn
7 years ago 25

Chakrabarty Controls on Isolated DNA Sequences, not Mayo*

Unfortunately this unspecific remand by the Supreme Court in AMP vacates as well the two-to-one ruling by this same Federal Circuit panel (Judges Lourie and Moore in …
By Eric Guttag
7 years ago 14

Is Your Patent Portfolio Safe from the Supreme Court?

The Prometheus decision shows that you can never know for sure what the outcome will be once you arrive at the Supreme Court. We also know that …

The Way Forward from Mayo Collaborative Services is through the Classen Immunotherapies Remand*

The reasoning in Mayo Collaborative Services makes no patent law logical sense on numerous grounds, including disregarding an important paragraph in the Supreme Court’s 1981 case of …
By Eric Guttag
7 years ago 14